Caption Management, LLC Xenon Pharmaceuticals Inc. Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Caption Management, LLC holds 231,700 shares of XENE stock, worth $9.89 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
231,700
Previous 256,700
9.74%
Holding current value
$9.89 Million
Previous $8.61 Million
15.79%
% of portfolio
0.09%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
223Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$230 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$185 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$154 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$153 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$136 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.66B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...